Evidence map›Paper›PMID 35991134›Full record

ArticleComputational and mathematical methods in medicine2022

Nursing Countermeasures of Continuous Renal Replacement Treatment in End-Stage Renal Disease with Refractory Hypotension in the Context of Smart Health.

Liya Ma, Jianli Guo, Hongwei Sun, Nan Li, MeiXuan Lv, Bing Shang

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liya MaEndoscopy Center, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161006 Heilongjiang, China.
Jianli GuoEndoscopy Center, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161006 Heilongjiang, China.ORCID https://orcid.org/0000-0003-1603-8364
Hongwei SunEndoscopy Center, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161006 Heilongjiang, China.
Nan LiEndoscopy Center, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161006 Heilongjiang, China.
MeiXuan LvEndoscopy Center, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161006 Heilongjiang, China.
Bing ShangEndoscopy Center, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161006 Heilongjiang, China.
Qiqihar Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work is aimed at exploring the nursing strategies and effects of continuous renal replacement therapy (CRRT) for end-stage renal disease (ESRD) with refractory hypotension under the background of smart health. 40 ESRD patients with refractory hypotension who received CRRT treatment were enrolled as the research objects and were randomly rolled into the intervention group and the control group, with 20 cases in each group. Patients in the control group received routine nursing, and those in the intervention group received individualized nursing. The incidence of hypotension, dry body weight, serous cavity effusion, renal function indicators (blood urea nitrogen (BUN) and creatinine (Cre)), and patient satisfaction were compared between the two groups. The results showed that the probability of hypotension in the intervention group was 9.38%, which was lower than that in the control group (34.38%). The probability of early termination of dialysis in the intervention group was 0%, which was lower than that in the control group (18.75%), and the difference was statistically significant (

Indexed as

Acute Kidney InjuryHypotensionKidney Failure, ChronicHumansKidneyRenal Replacement Therapy

Identifiers

PMID35991134
PMCPMC9385371
OpenAlexW4292666304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.